http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0408526-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F216-1425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L2203-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F8-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F216-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F222-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L71-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F216-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L71-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate | 2004-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecbe04542c441327553db24fa0e12d47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6257cdf56c9e325ef53a024dfe72f8dc |
| publicationDate | 2006-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0408526-A |
| titleOfInvention | a pharmacologically acceptable copolymer or salt thereof, pharmaceutical composition, modifier capable of modifying a complex protein or analogue or variant thereof, methods for prolonging the time that a protein or analog or variant thereof is retained in the blood stream following administration to a patient, and for the treatment or prophylaxis of a disease in a patient who is susceptible to a protein or an analog or variant thereof, and, use of the complex |
| abstract | "COPOLYMER OR A SALT OF THIS PHARMACOLOGICALLY ACCEPTABLE, PHARMACEUTICAL COMPOSITION, MODIFIER ABLE TO MODIFY A PROTEIN OR ANALOG OR VARIANT OF THIS, COMPLEX, METHODS TO EXTEND THE TIME IN WHICH A PROTEIN IS NOT INTENDED WITH THE ANALYZE TO A PATIENT, AND FOR THE TREATMENT OR PROPHILAXY OF A DISEASE IN A PATIENT THAT IS SUSTAINABLE TO A PROTEIN OR ANALOG OR VARIANT OF THIS AND USE OF THE COMPLEX ". A pharmacologically acceptable copolymer or salt thereof is provided which contains, as constitutional units, (a) one or more structural units of formula (I): wherein m is an integer from 3 to 100, Alq represents alkylene and R¬ 1¬ and R¬ 2¬ are the same or different and each represents optionally substituted hydrogen or alkyl and (b) one or more structural units of formula (II): wherein R¬ 3¬ represents hydroxyl, optionally substituted alkoxy, aryloxy optionally substituted or a group represented by the formula -NR¬4¬R¬5¬, wherein R¬4¬ and R¬5¬ are the same or different and each represents optionally substituted hydrogen or alkyl. There is further provided a pharmaceutical composition comprising said copolymer, a protein modifier comprising said copolymer, a complex of said copolymer with a protein, a method of preventing or treating disease using said complex, the use of said complex in manufacturing of a medicament for preventing or treating diseases and methods for the synthesis of said copolymers and said complexes. |
| priorityDate | 2003-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310 |
Total number of triples: 34.